Gulf shipping traffic steady amid uncertainty of peace talks

The management team at American Express (AXP -0.38%) is optimistic about the future. Executives expect the company’s revenue to increase at 10% per year over the long term, with diluted earnings per share rising at a mid-teens rate. This is a meaningful tailwind that can help fuel investor returns. This financial stock, which is a…

Payments have spent years getting faster. Fraud detection has not always kept pace. New August research from PYMNTS Intelligence, in collaboration with Plaid, shows that 47% of firms surveyed can’t detect suspected fraud in real time or within minutes. That is despite widespread use of sophisticated defenses: 90% use rules-based scoring before authorization, 83% use…

Experian’s new ChatGPT-powered credit card app highlights how consumer credit marketplaces are adapting their revenue models for the AI era. For Experian, as well as for platforms such as NerdWallet, CardRates.com, and Credit Karma, AI creates a new way to frame credit card selection, deepen consumer engagement, and potentially expand acquisition economics. PaymentsJournal has followed…

ExxonMobil (XOM +2.22%) and Angola’s National Oil, Gas and Biofuels Agency (ANPG) announced a new oil discovery off Angola’s coast in a field that has already produced a massive 2.7 billion barrels of oil since the first oil discovery there in 1998. Exxon’s shares closed 2.2% higher following the news. For shareholders, the attractiveness lies…

For veterans and military spouses, entrepreneurship provides a powerful pathway to continue serving—by turning military-honed skills, such as leadership, adaptability and resilience, into small business ownership. Sometimes, navigating the transition from military life to business ownership comes with unique challenges. That’s where SBA resource partners make a big difference. Through SBA grants, the following veteran…

Novo Nordisk‘s CEO sought to reassure investors that its Wegovy pill can drive profitable growth despite lower prices, as investors sent the drugmaker’s shares lower following quarterly results. The Danish company raised its full-year guidance after reporting better-than-expected adjusted sales and operating profit, but investors remained focused on pricing pressure, the quality of the earnings…